Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.
Saved in:
| Title: | Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer. |
|---|---|
| Authors: | Chipidza, Fallon E.1 fchipidza@dfci.harvard.edu, Alshalalfa, Mohammed1,2, Mahal, Brandon A.1, Karnes, R. Jeffrey3, Yang Liu4, Davicioni, Elai4, Martin, Neil E.1, Mouw, Kent W.1, Feng, Felix Y.2, Nguyen, Paul L.1, Muralidhar, Vinayak1 |
| Source: | Clinical Genitourinary Cancer. Jun2021, Vol. 19 Issue 3, p246-254. 14p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
